StockData
CTT Pharmaceutical Holdings, Inc. logo

CTT Pharmaceutical Holdings, Inc. (CTTH) stock

CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2015, quarter ended Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)

Close on Oct 16, 2026Market cap $1.26MP/E –Yield –

CTT Pharmaceutical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

CTT Pharmaceutical's operating income for the twelve months ending Jun 30, 2014 was $79.95K. For fiscal 2014 it was -$672.16K. The highest annual figure on record is -$18.91K in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2014Dec 31, 2014-$672.16K–
FY2013Dec 31, 2013-$18.91K–
FY2012Dec 31, 2012-$1.19M–
FY2011Dec 31, 2011-$757.94K–
FY2010Dec 31, 2010-$2.07M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2015Mar 31, 2015-$337.05K–
Q2 FY2014Jun 30, 2014-$22.32K–
Q1 FY2014Mar 31, 2014-$1.67K–
Q4 FY2013Dec 31, 2013$129.68K–
Q3 FY2013Sep 30, 2013-$25.74K–
Q2 FY2013Jun 30, 2013-$62.54K–
Q1 FY2013Mar 31, 2013-$60.32K–
Q4 FY2012Dec 31, 2012-$202.04K–
Q3 FY2012Sep 30, 2012-$118.53K–
Q2 FY2012Jun 30, 2012-$191.52K–
Q1 FY2012Mar 31, 2012-$582.82K–
Q4 FY2011Dec 31, 2011-$186.89K–
Q3 FY2011Sep 30, 2011-$107.42K–
Q2 FY2011Jun 30, 2011-$436.77K–
Q1 FY2011Mar 31, 2011-$26.86K–
Q4 FY2010Dec 31, 2010-$559.86K–
Q3 FY2010Sep 30, 2010-$981.65K–
Q2 FY2010Jun 30, 2010-$385.63K–

More CTT Pharmaceutical figures

See a number that looks wrong?